RAP - ResApp Health

[frugal.rock]

Too many stocks in too many watchlists.
I had better start a new watchlist that I check charts in daily, otherwise I totally miss moves and trend changes that I have been waiting for, for a long long time.

Dagnammit.

 

[frugal.rock]

Shiver me timbers...

 

[kenny]

Hopeful that more news in the pipe after this Quarterly Report. In summary;

• ResAppDx now live on Alodokter (Indonesia’s largest telehealth provider) and Doctors on Demand’s telehealth platforms.
  • the app is already live in Switzerland (Medgate), and Australia (Coviu, Phenix)
• Janssen Pharmaceutica NV to use ResAppDx technology in a respiratory syncytial virus (RSV) clinical trial. Signed 3 year licence.
• Emerging markets 3 year distribution agreement signed with Sanrai International § Partnership with Carepath Technologies GmbH for remote monitoring and management of COPD patients
• Completed recruitment in clinical studies in India and the United States to develop an instant smartphone-based COVID-19 screening test. This is where I see promising results coming through as recruitment completed in November 2021.
• SleepCheckRx US FDA 510(k) premarket notification submission may seethe FDA response in February.
• Customer receipts for the quarter increased to $124,000 (Q1: $7,000)

 

[frugal.rock]

This hasn't made it into any of my shorter term trades that I can rememver, however, I may consider it as part of a newer longer term strategy... after FA approval of course.

 

[BeeDeeStocks]

Hi all I saw that ResApp reported positive results from their Covid-19 smartphone test! As a result they ere up by 48.4 per cent, so can we expect them to continue to rise as they look for a company to partner with to help increase commercialisation?

 

[Dona Ferentes]

ResApp is in a trading halt related to the status of a $100 million takeover bid from global pharmaceutical giant Pfizer.

ResApp gave no detail on the reason for the halt other than considerations around a draft independent expert report on the bid.

 

[System]

On September 27th, 2022, ResApp Health Limited (RAP) was removed from the ASX's Official List in accordance with Listing Rule 17.11, following implementation of the scheme of arrangement between RAP and its shareholders in connection with the acquisition of of all the issued capital in RAP by Pfizer Australia Holdings Pty Limited.